AI in Action E184: Brandon Allgood, SVP of Data Science & AI at Valo Health

The Alldus Podcast2 (7) Min

Welcome to episode 184 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today's guest is Brandon Allgood, Senior Vice President of Data Science & AI at Valo Health in San Francisco. Founded in 2019, Valo are using cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. With 15 years of experience in large scale cloud and distributed computing, AI and mathematical modeling, Brandon currently manages the development and application of Valo's AI platform and is responsible for Valo's overall technological vision.

Valo’s Opal Computational PlatformTM, a cloud generation, fully-integrated, componentized, end-to-end drug development platform, drug development is positioned to be transformed into a far more efficient process with life-changing treatments created in potentially half the time at far less cost and with far fewer failures. The Opal Platform makes it possible for scientists to review human data to discover previously unsuspected associations between genetic markers and disease and design and discover proprietary new molecules.

In the episode, Brandon will discuss:

Interesting roles he’s held throughout his career 

Challenges they are solving at Valo Health 

Their impact in drug discovery and clinical trials 

Future innovations in pharma that excite him 

Tackling bias and unfairness in AI 

How to build a successful data science team 

To find out more about Brandon and all the great work happening at Valo Health, please check out the website or follow them on Twitter @ValoHealth. You can also follow him on Twitter @allg00d or connect with Brandon on Linkedin.

What did you think of Brandon's podcast? Where do you see the future of AI and Data Science in the Healthcare industry heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to the AI in Action Podcast:

Comments (1)

Add a comment

  • Kelly Murphy Avatar

    Kelly Murphy

    Really inciteful podcast - particularly about developed "targets" coming out of non-relevant - rather than human systems.
    It was also the 1st time that I've heard that Alzheimer's isn't a single disease but "undoubtedly tens of diseases". And finally, although I've seen it graphically within Eroom's Law, hearing that to bring a drug to market, the tab is $2.5 billion - fully amortized cost over all failures – given that 95% of all drugs fail - is mind blowing.

Leave a Comment

* Indicates a required field